ArticleOncogene2016
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML.
O Lindblad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
74 papers cite itlatest 60 shown
this papercites it
ArticleOncogene2016
O Lindblad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.